J&J Wins $465 Million Opioid Verdict Reversal in Oklahoma

November 9, 2021

In a stunning decision, Oklahoma’s supreme court has reversed a $465 million verdict against Johnson & Johnson (J&J), regarding allegations the drugmaker contributed to the state’s public health crisis by misleadingly hawking prescription opioids.
Source: Drug Industry Daily

Posted in Drug Industry Daily